MARC Record from marc_columbia

LEADER: 03411fam a2200433 a 4500
001 3979386
005 20221027012915.0
008 930610t19941994maua b 001 0 eng c
010 $a 93021904
020 $a0792324102 (alk. paper)
035 $a(OCoLC)30030576
035 $a(OCoLC)ocm30030576
035 $9AHT2899HS
035 $a(NNC)3979386
035 $a3979386
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M
050 00 $aRC685.I6$bI83 1994
060 00 $aW1 DE997VME v.148
082 00 $a616.1/23$220
245 00 $aIschemic preconditioning :$bthe concept of endogenous cardioprotection /$cedited by Karin Przyklenk, Robert A. Kloner, and Derek M. Yellon.
260 $aBoston :$bKluwer Academic Publishers ;$aNorwell, Mass. :$bKluwer Academic Publishers,$c[1994], ©1994.
300 $axii, 196 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aDevelopments in cardiovascular medicine ;$vDICM 148
504 $aIncludes bibliographical references and index.
505 0 $aI. Ischemic Preconditioning: Benefits and Limitations in Experimental Models of Ischemia/Reperfusion. 1. What is ischemic preconditioning? / Charles E. Murry, Robert B. Jennings and Keith A. Reimer. 2. Preconditioning and ischemia- and reperfusion-induced arrhythmias / Clive S. Lawson and David J. Hearse. 3. Preconditioning and myocardial contractile function / Michel Ovize, Robert A. Kloner and Karin Przyklenk. 4. Preconditioning and the coronary vasculature / Barbara Bauer, Robert A. Kloner and Karin Przyklenk -- II. Mechanisms of Cardioprotection by Preconditioning: Theories and Controversies. 5. Role of altered energy metabolism in ischemic preconditioning / Keith A. Reimer, Richard S. Vander Heide, Charles E. Murry and Robert B. Jennings. 6. Stress proteins, heat stress, and myocardial protection / Michael S. Marber, Richard J. Heads and Derek M. Yellon. 7. Role of ATP-sensitive potassium channels in ischemic preconditioning / Garrett J. Gross, Zhenhai Yao and John A. Auchampach.
505 0 $a8. Adenosine and the antiinfarct effects of preconditioning / James M. Downey, Yongge Liu and Kirsti Ytrehus. 9. Synopsis of ischemic preconditioning: What have we learned since 1986? / Karin Przyklenk, Robert A. Kloner and Peter Whittaker -- III. Ischemic Preconditioning: Laboratory Curiosity Or Clinical Promise? 10. Is preconditioning relevant to clinical medicine? / Robert A. Kloner and Karin Przyklenk.
650 0 $aMyocardial infarction$xPrevention.$0http://id.loc.gov/authorities/subjects/sh2010103007
650 0 $aCoronary heart disease.$0http://id.loc.gov/authorities/subjects/sh85032870
650 0 $aHeart$xAdaptation.$0http://id.loc.gov/authorities/subjects/sh2008004630
650 2 $aMyocardial Ischemia.$0https://id.nlm.nih.gov/mesh/D017202
650 2 $aCardiomyopathies$xprevention & control.$0https://id.nlm.nih.gov/mesh/D009202Q000517
650 2 $aAdaptation, Physiological.$0https://id.nlm.nih.gov/mesh/D000222
700 1 $aPrzyklenk, Karin,$d1956-$0http://id.loc.gov/authorities/names/n92803394
700 1 $aKloner, Robert A.$0http://id.loc.gov/authorities/names/n83189911
700 1 $aYellon, Derek M.$0http://id.loc.gov/authorities/names/n84068942
830 0 $aDevelopments in cardiovascular medicine ;$vv. 148.$0http://id.loc.gov/authorities/names/n42009022
852 00 $boff,hsl$hRC685.I6$iI83 1994